Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:29 am
| PEG Ratio | 6.02 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bata India Ltd, a prominent player in the footwear industry, reported a market capitalization of ₹12,077 Cr and a share price of ₹939. The company has shown resilience in its sales performance, with total revenue from operations rising from ₹3,056 Cr in FY 2020 to ₹3,489 Cr in FY 2025. The trailing twelve months (TTM) sales stood at ₹3,450 Cr, indicating steady demand for its products. Quarterly sales demonstrated fluctuations, peaking at ₹958 Cr in June 2023 and declining to ₹779 Cr by March 2023. The sales figures for the most recent quarter, September 2023, recorded ₹819 Cr, suggesting a potential rebound as the festive season approaches. Notably, the operating profit margin (OPM) improved from 18% in FY 2022 to 22% in FY 2025, reflecting effective cost management strategies. Overall, Bata India’s revenue trajectory demonstrates a recovery post-pandemic challenges, aligning with industry trends of increasing consumer spending on footwear.
Profitability and Efficiency Metrics
Bata India reported a net profit of ₹171 Cr for FY 2025, with an impressive growth trajectory from ₹103 Cr in FY 2022. The net profit margin improved from 4.31% in FY 2022 to 9.47% in FY 2025, showcasing enhanced profitability amidst rising sales. The company’s return on equity (ROE) stood at 15.6%, while return on capital employed (ROCE) was reported at 15.1%, reflecting efficient utilization of capital. Additionally, the interest coverage ratio (ICR) of 6.25x indicates a comfortable capacity to cover interest expenses, which rose gradually from ₹118 Cr in FY 2023 to ₹141 Cr in FY 2025. Despite these strengths, the cash conversion cycle (CCC) remained at 123 days, with inventory days at 195 and debtor days at 12, signifying room for improvement in operational efficiency. The fluctuation in quarterly net profit, notably a decline to ₹14 Cr in September 2025, raises concerns about consistent performance.
Balance Sheet Strength and Financial Ratios
Bata India’s balance sheet reveals a total asset value of ₹3,823 Cr as of FY 2025, supported by reserves of ₹1,511 Cr and borrowings amounting to ₹1,446 Cr. The company’s debt-to-equity ratio is manageable, with borrowings constituting approximately 38% of its equity base. The price-to-book value (P/BV) ratio stood at 9.95x, indicating a premium valuation compared to typical sector ranges, which often hover around 5-6x. The current ratio of 1.84x suggests a solid liquidity position, although the quick ratio of 0.96x indicates potential liquidity constraints when excluding inventory. Additionally, the company has consistently increased its dividend payout ratio, which rose to 85.51% in FY 2025, reflecting a commitment to returning capital to shareholders. However, the rise in depreciation expenses, which reached ₹371 Cr in FY 2025, may impact future profitability if not matched by revenue growth.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bata India demonstrates a stable promoter holding of 50.16%, which has remained consistent over recent quarters. Foreign institutional investors (FIIs) held 6.89%, while domestic institutional investors (DIIs) accounted for 29.39% of the equity, indicating robust institutional confidence. The public shareholding stood at 13.55%, and the total number of shareholders reached 236,169 as of September 2025. The gradual increase in institutional holdings, particularly among DIIs, reflects growing confidence in the company’s strategic direction and operational performance. However, the slight decline in FII participation from 8.24% in March 2024 to 6.89% in September 2025 may signal cautious sentiment among foreign investors. Overall, the shareholding pattern suggests a solid base of support, critical for maintaining stability in stock performance.
Outlook, Risks, and Final Insight
Bata India’s outlook appears cautiously optimistic, supported by revenue growth and improving profitability metrics. However, challenges such as fluctuating quarterly performance and high valuation ratios could pose risks to investor sentiment. The company’s ability to sustain its operating profit margins amidst rising costs and potential supply chain disruptions remains a key concern. Additionally, the high cash conversion cycle could limit operational flexibility. On the positive side, Bata’s established brand presence and recovery in consumer spending trends position it well in the competitive footwear market. Future growth could hinge on effective inventory management and leveraging digital channels to enhance sales. If Bata can navigate these risks effectively while capitalizing on market opportunities, it may well sustain its growth trajectory and deliver value to shareholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Campus Activewear Ltd | 7,783 Cr. | 255 | 315/210 | 62.9 | 26.0 | 0.39 % | 20.1 % | 17.2 % | 5.00 |
| AKI India Ltd | 64.7 Cr. | 6.27 | 16.2/6.00 | 32.7 | 8.35 | 0.00 % | 4.54 % | 1.80 % | 2.00 |
| Relaxo Footwears Ltd | 9,965 Cr. | 400 | 602/375 | 57.2 | 84.7 | 0.75 % | 11.2 % | 8.31 % | 1.00 |
| Liberty Shoes Ltd | 450 Cr. | 264 | 510/260 | 33.8 | 134 | 0.00 % | 9.99 % | 7.20 % | 10.0 |
| Khadim India Ltd | 320 Cr. | 174 | 330/153 | 22.3 | 90.2 | 0.00 % | 9.34 % | 2.20 % | 10.0 |
| Industry Average | 6,084.40 Cr | 337.55 | 45.48 | 77.04 | 0.53% | 11.71% | 8.72% | 5.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 830 | 900 | 779 | 958 | 819 | 903 | 798 | 945 | 837 | 919 | 788 | 942 | 801 |
| Expenses | 669 | 694 | 597 | 719 | 637 | 721 | 616 | 760 | 663 | 719 | 610 | 743 | 656 |
| Operating Profit | 161 | 206 | 182 | 240 | 182 | 182 | 182 | 185 | 174 | 200 | 178 | 199 | 145 |
| OPM % | 19% | 23% | 23% | 25% | 22% | 20% | 23% | 20% | 21% | 22% | 23% | 21% | 18% |
| Other Income | 12 | 8 | 10 | 13 | -25 | 11 | 22 | 151 | 18 | -1 | 23 | 12 | 13 |
| Interest | 27 | 29 | 27 | 28 | 28 | 29 | 31 | 31 | 32 | 31 | 35 | 35 | 34 |
| Depreciation | 74 | 75 | 76 | 81 | 82 | 86 | 90 | 87 | 90 | 90 | 104 | 106 | 105 |
| Profit before tax | 72 | 110 | 88 | 144 | 46 | 78 | 83 | 217 | 70 | 77 | 62 | 70 | 19 |
| Tax % | 24% | 24% | 26% | 26% | 26% | 26% | 23% | 20% | 26% | 24% | 26% | 26% | 28% |
| Net Profit | 55 | 83 | 66 | 107 | 34 | 58 | 64 | 174 | 52 | 59 | 46 | 52 | 14 |
| EPS in Rs | 4.27 | 6.47 | 5.11 | 8.32 | 2.64 | 4.51 | 4.95 | 13.54 | 4.04 | 4.57 | 3.57 | 4.05 | 1.08 |
Last Updated: January 2, 2026, 7:02 am
Below is a detailed analysis of the quarterly data for Bata India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 801.00 Cr.. The value appears to be declining and may need further review. It has decreased from 942.00 Cr. (Jun 2025) to 801.00 Cr., marking a decrease of 141.00 Cr..
- For Expenses, as of Sep 2025, the value is 656.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 743.00 Cr. (Jun 2025) to 656.00 Cr., marking a decrease of 87.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 199.00 Cr. (Jun 2025) to 145.00 Cr., marking a decrease of 54.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Jun 2025) to 18.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 35.00 Cr. (Jun 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 105.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.00 Cr. (Jun 2025) to 105.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Jun 2025) to 19.00 Cr., marking a decrease of 51.00 Cr..
- For Tax %, as of Sep 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 28.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Jun 2025) to 14.00 Cr., marking a decrease of 38.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.08. The value appears to be declining and may need further review. It has decreased from 4.05 (Jun 2025) to 1.08, marking a decrease of 2.97.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:34 am
| Metric | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,065 | 2,694 | 2,423 | 2,474 | 2,634 | 2,931 | 3,056 | 1,708 | 2,388 | 3,452 | 3,479 | 3,489 | 3,450 |
| Expenses | 1,728 | 2,343 | 2,129 | 2,178 | 2,271 | 2,441 | 2,210 | 1,540 | 1,960 | 2,647 | 2,682 | 2,736 | 2,729 |
| Operating Profit | 338 | 351 | 294 | 296 | 364 | 490 | 846 | 169 | 427 | 804 | 797 | 753 | 721 |
| OPM % | 16% | 13% | 12% | 12% | 14% | 17% | 28% | 10% | 18% | 23% | 23% | 22% | 21% |
| Other Income | 18 | 75 | 97 | 18 | 49 | 66 | 66 | 87 | 54 | 39 | 19 | 186 | 47 |
| Interest | 13 | 18 | 16 | 15 | 15 | 14 | 129 | 108 | 99 | 118 | 126 | 141 | 135 |
| Depreciation | 59 | 79 | 79 | 65 | 60 | 64 | 296 | 265 | 242 | 295 | 339 | 371 | 405 |
| Profit before tax | 283 | 329 | 297 | 234 | 337 | 478 | 487 | -117 | 140 | 430 | 351 | 426 | 229 |
| Tax % | 33% | 30% | 27% | 32% | 35% | 31% | 32% | -23% | 26% | 25% | 25% | 22% | |
| Net Profit | 191 | 231 | 217 | 159 | 221 | 329 | 329 | -89 | 103 | 323 | 263 | 331 | 171 |
| EPS in Rs | 14.86 | 18.00 | 16.91 | 12.37 | 17.16 | 25.60 | 25.59 | -6.95 | 8.01 | 25.13 | 20.42 | 25.73 | 13.27 |
| Dividend Payout % | 22% | 18% | 21% | 28% | 23% | 24% | 16% | -58% | 680% | 54% | 59% | 74% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.73% | 38.99% | 48.87% | 0.00% | -127.05% | 215.73% | 213.59% | -18.58% | 25.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 65.72% | 9.88% | -48.87% | -127.05% | 342.78% | -2.14% | -232.17% | 44.43% |
Bata India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 3% |
| 3 Years: | 13% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -6% |
| 3 Years: | 33% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | -2% |
| 3 Years: | -13% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 12:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:27 am
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 64 |
| Reserves | 776 | 957 | 1,157 | 1,260 | 1,410 | 1,678 | 1,830 | 1,694 | 1,750 | 1,374 | 1,463 | 1,511 | 1,460 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 1,249 | 1,032 | 1,094 | 1,246 | 1,357 | 1,446 | 1,378 |
| Other Liabilities | 542 | 616 | 512 | 599 | 667 | 732 | 589 | 542 | 616 | 587 | 466 | 801 | 788 |
| Total Liabilities | 1,382 | 1,637 | 1,733 | 1,923 | 2,141 | 2,474 | 3,732 | 3,332 | 3,525 | 3,272 | 3,350 | 3,823 | 3,691 |
| Fixed Assets | 248 | 309 | 304 | 268 | 296 | 317 | 1,369 | 1,120 | 1,226 | 1,392 | 1,509 | 1,800 | 1,688 |
| CWIP | 24 | 48 | 19 | 30 | 12 | 17 | 20 | 34 | 5 | 4 | 4 | 14 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 25 |
| Other Assets | 1,110 | 1,280 | 1,410 | 1,625 | 1,833 | 2,140 | 2,343 | 2,179 | 2,294 | 1,876 | 1,837 | 2,008 | 1,978 |
| Total Assets | 1,382 | 1,637 | 1,733 | 1,923 | 2,141 | 2,474 | 3,732 | 3,332 | 3,525 | 3,272 | 3,350 | 3,823 | 3,691 |
Below is a detailed analysis of the balance sheet data for Bata India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 64.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,460.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,511.00 Cr. (Mar 2025) to 1,460.00 Cr., marking a decrease of 51.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,378.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,446.00 Cr. (Mar 2025) to 1,378.00 Cr., marking a decrease of 68.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 788.00 Cr.. The value appears to be improving (decreasing). It has decreased from 801.00 Cr. (Mar 2025) to 788.00 Cr., marking a decrease of 13.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,691.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,823.00 Cr. (Mar 2025) to 3,691.00 Cr., marking a decrease of 132.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,688.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,800.00 Cr. (Mar 2025) to 1,688.00 Cr., marking a decrease of 112.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 24.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,978.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,008.00 Cr. (Mar 2025) to 1,978.00 Cr., marking a decrease of 30.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,691.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,823.00 Cr. (Mar 2025) to 3,691.00 Cr., marking a decrease of 132.00 Cr..
Notably, the Reserves (1,460.00 Cr.) exceed the Borrowings (1,378.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Mar 2015n n 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 338.00 | 351.00 | 294.00 | 296.00 | 364.00 | 490.00 | 845.00 | 168.00 | 426.00 | 803.00 | 796.00 | 752.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 8 | 11 | 10 | 12 | 8 | 8 | 17 | 11 | 9 | 8 | 12 |
| Inventory Days | 224 | 208 | 217 | 225 | 232 | 238 | 246 | 265 | 292 | 218 | 227 | 195 |
| Days Payable | 110 | 105 | 104 | 129 | 146 | 146 | 142 | 192 | 153 | 99 | 73 | 84 |
| Cash Conversion Cycle | 123 | 111 | 124 | 106 | 99 | 100 | 112 | 90 | 150 | 128 | 162 | 123 |
| Working Capital Days | 36 | 39 | 61 | 51 | 56 | 46 | 28 | 10 | 33 | 27 | 43 | 16 |
| ROCE % | 40% | 34% | 22% | 22% | 25% | 31% | 25% | -0% | 8% | 20% | 19% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund | 4,827,607 | 1.11 | 482.37 | 3,094,295 | 2025-12-08 05:14:22 | 56.02% |
| Mirae Asset ELSS Tax Saver Fund | 3,362,508 | 1.23 | 335.98 | 1,482,414 | 2025-12-08 05:06:49 | 126.83% |
| Mirae Asset Midcap Fund | 2,513,023 | 1.37 | 251.1 | N/A | N/A | N/A |
| Canara Robeco Large and Mid Cap Fund | 2,043,454 | 0.78 | 204.18 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 1,900,000 | 0.45 | 189.85 | N/A | N/A | N/A |
| Quant Small Cap Fund | 1,593,619 | 0.53 | 159.23 | 1,832,323 | 2025-12-15 02:09:03 | -13.03% |
| ICICI Prudential Value Fund | 1,591,349 | 0.26 | 159.01 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 560,908 | 0.08 | 56.05 | N/A | N/A | N/A |
| HDFC Large and Mid Cap Fund | 372,252 | 0.13 | 37.2 | N/A | N/A | N/A |
| Bandhan Value Fund | 363,645 | 0.35 | 36.34 | 388,339 | 2025-12-15 02:09:03 | -6.36% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 25.73 | 20.42 | 25.13 | 8.01 | -6.95 |
| Diluted EPS (Rs.) | 25.73 | 20.42 | 25.13 | 8.01 | -6.95 |
| Cash EPS (Rs.) | 54.62 | 46.81 | 48.07 | 26.84 | 13.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 122.54 | 118.80 | 111.90 | 141.19 | 136.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 122.54 | 118.80 | 111.90 | 141.19 | 136.79 |
| Revenue From Operations / Share (Rs.) | 271.44 | 270.65 | 268.55 | 185.77 | 132.93 |
| PBDIT / Share (Rs.) | 62.48 | 65.95 | 64.77 | 36.92 | 19.94 |
| PBIT / Share (Rs.) | 33.59 | 39.57 | 41.83 | 18.09 | -0.65 |
| PBT / Share (Rs.) | 33.17 | 27.28 | 33.44 | 10.87 | -9.07 |
| Net Profit / Share (Rs.) | 25.73 | 20.42 | 25.13 | 8.01 | -6.95 |
| NP After MI And SOA / Share (Rs.) | 25.73 | 20.42 | 25.13 | 8.01 | -6.95 |
| PBDIT Margin (%) | 23.01 | 24.36 | 24.11 | 19.87 | 14.99 |
| PBIT Margin (%) | 12.37 | 14.61 | 15.57 | 9.73 | -0.49 |
| PBT Margin (%) | 12.22 | 10.07 | 12.45 | 5.85 | -6.82 |
| Net Profit Margin (%) | 9.47 | 7.54 | 9.35 | 4.31 | -5.22 |
| NP After MI And SOA Margin (%) | 9.47 | 7.54 | 9.35 | 4.31 | -5.22 |
| Return on Networth / Equity (%) | 20.99 | 17.19 | 22.45 | 5.67 | -5.07 |
| Return on Capital Employeed (%) | 14.96 | 19.45 | 21.95 | 8.58 | -0.32 |
| Return On Assets (%) | 8.64 | 7.83 | 9.87 | 2.92 | -2.68 |
| Asset Turnover Ratio (%) | 0.97 | 1.05 | 1.02 | 0.69 | 0.48 |
| Current Ratio (X) | 1.84 | 2.11 | 1.96 | 2.45 | 2.61 |
| Quick Ratio (X) | 0.96 | 0.84 | 0.86 | 1.38 | 1.75 |
| Inventory Turnover Ratio (X) | 4.00 | 0.26 | 0.29 | 0.33 | 0.14 |
| Dividend Payout Ratio (NP) (%) | 85.51 | 66.09 | 216.86 | 49.91 | -57.56 |
| Dividend Payout Ratio (CP) (%) | 40.28 | 28.84 | 113.38 | 14.90 | 29.30 |
| Earning Retention Ratio (%) | 14.49 | 33.91 | -116.86 | 50.09 | 157.56 |
| Cash Earning Retention Ratio (%) | 59.72 | 71.16 | -13.38 | 85.10 | 70.70 |
| Interest Coverage Ratio (X) | 6.25 | 7.24 | 7.72 | 5.11 | 2.47 |
| Interest Coverage Ratio (Post Tax) (X) | 2.62 | 3.59 | 3.99 | 2.11 | 0.18 |
| Enterprise Value (Cr.) | 15038.26 | 17126.47 | 17706.92 | 24247.77 | 16956.86 |
| EV / Net Operating Revenue (X) | 4.31 | 4.92 | 5.13 | 10.16 | 9.93 |
| EV / EBITDA (X) | 18.73 | 20.21 | 21.27 | 51.10 | 66.17 |
| MarketCap / Net Operating Revenue (X) | 4.49 | 5.04 | 5.28 | 10.56 | 10.57 |
| Retention Ratios (%) | 14.48 | 33.90 | -116.86 | 50.08 | 157.56 |
| Price / BV (X) | 9.95 | 11.48 | 12.68 | 13.90 | 10.27 |
| Price / Net Operating Revenue (X) | 4.49 | 5.04 | 5.28 | 10.56 | 10.57 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
After reviewing the key financial ratios for Bata India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
- For Diluted EPS (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 54.62. This value is within the healthy range. It has increased from 46.81 (Mar 24) to 54.62, marking an increase of 7.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.54. It has increased from 118.80 (Mar 24) to 122.54, marking an increase of 3.74.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.54. It has increased from 118.80 (Mar 24) to 122.54, marking an increase of 3.74.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 271.44. It has increased from 270.65 (Mar 24) to 271.44, marking an increase of 0.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 62.48. This value is within the healthy range. It has decreased from 65.95 (Mar 24) to 62.48, marking a decrease of 3.47.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.59. This value is within the healthy range. It has decreased from 39.57 (Mar 24) to 33.59, marking a decrease of 5.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 33.17. This value is within the healthy range. It has increased from 27.28 (Mar 24) to 33.17, marking an increase of 5.89.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 25.73. This value is within the healthy range. It has increased from 20.42 (Mar 24) to 25.73, marking an increase of 5.31.
- For PBDIT Margin (%), as of Mar 25, the value is 23.01. This value is within the healthy range. It has decreased from 24.36 (Mar 24) to 23.01, marking a decrease of 1.35.
- For PBIT Margin (%), as of Mar 25, the value is 12.37. This value is within the healthy range. It has decreased from 14.61 (Mar 24) to 12.37, marking a decrease of 2.24.
- For PBT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has increased from 10.07 (Mar 24) to 12.22, marking an increase of 2.15.
- For Net Profit Margin (%), as of Mar 25, the value is 9.47. This value is within the healthy range. It has increased from 7.54 (Mar 24) to 9.47, marking an increase of 1.93.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.47. This value is within the healthy range. It has increased from 7.54 (Mar 24) to 9.47, marking an increase of 1.93.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.99. This value is within the healthy range. It has increased from 17.19 (Mar 24) to 20.99, marking an increase of 3.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.96. This value is within the healthy range. It has decreased from 19.45 (Mar 24) to 14.96, marking a decrease of 4.49.
- For Return On Assets (%), as of Mar 25, the value is 8.64. This value is within the healthy range. It has increased from 7.83 (Mar 24) to 8.64, marking an increase of 0.81.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.05 (Mar 24) to 0.97, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 2.11 (Mar 24) to 1.84, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.84 (Mar 24) to 0.96, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.00. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 4.00, marking an increase of 3.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.51. This value exceeds the healthy maximum of 50. It has increased from 66.09 (Mar 24) to 85.51, marking an increase of 19.42.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 40.28. This value is within the healthy range. It has increased from 28.84 (Mar 24) to 40.28, marking an increase of 11.44.
- For Earning Retention Ratio (%), as of Mar 25, the value is 14.49. This value is below the healthy minimum of 40. It has decreased from 33.91 (Mar 24) to 14.49, marking a decrease of 19.42.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 59.72. This value is within the healthy range. It has decreased from 71.16 (Mar 24) to 59.72, marking a decrease of 11.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.25. This value is within the healthy range. It has decreased from 7.24 (Mar 24) to 6.25, marking a decrease of 0.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.59 (Mar 24) to 2.62, marking a decrease of 0.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,038.26. It has decreased from 17,126.47 (Mar 24) to 15,038.26, marking a decrease of 2,088.21.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has decreased from 4.92 (Mar 24) to 4.31, marking a decrease of 0.61.
- For EV / EBITDA (X), as of Mar 25, the value is 18.73. This value exceeds the healthy maximum of 15. It has decreased from 20.21 (Mar 24) to 18.73, marking a decrease of 1.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.49. This value exceeds the healthy maximum of 3. It has decreased from 5.04 (Mar 24) to 4.49, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 14.48. This value is below the healthy minimum of 30. It has decreased from 33.90 (Mar 24) to 14.48, marking a decrease of 19.42.
- For Price / BV (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 3. It has decreased from 11.48 (Mar 24) to 9.95, marking a decrease of 1.53.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.49. This value exceeds the healthy maximum of 3. It has decreased from 5.04 (Mar 24) to 4.49, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bata India Ltd:
- Net Profit Margin: 9.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.96% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.99% (Industry Average ROE: 8.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 64 (Industry average Stock P/E: 45.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Footwears | 27B, Camac Street, Kolkata West Bengal 700016 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwani Windlass | Chairman & Ind.Director |
| Mr. Gunjan Shah | Managing Director & CEO |
| Mr. Amit Aggarwal | Director - Finance & CFO |
| Ms. Radha Rajappa | Independent Director |
| Mr. Ashok Kumar Barat | Independent Director |
| Mr. Mukesh Butani | Independent Director |
| Mr. Gerd Graehsler | Non Executive Director |
| Mr. Shaibal Sinha | Non Executive Director |
FAQ
What is the intrinsic value of Bata India Ltd?
Bata India Ltd's intrinsic value (as of 11 January 2026) is ₹969.96 which is 4.75% higher the current market price of ₹926.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹11,904 Cr. market cap, FY2025-2026 high/low of ₹1,425/914, reserves of ₹1,460 Cr, and liabilities of ₹3,691 Cr.
What is the Market Cap of Bata India Ltd?
The Market Cap of Bata India Ltd is 11,904 Cr..
What is the current Stock Price of Bata India Ltd as on 11 January 2026?
The current stock price of Bata India Ltd as on 11 January 2026 is ₹926.
What is the High / Low of Bata India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bata India Ltd stocks is ₹1,425/914.
What is the Stock P/E of Bata India Ltd?
The Stock P/E of Bata India Ltd is 64.0.
What is the Book Value of Bata India Ltd?
The Book Value of Bata India Ltd is 119.
What is the Dividend Yield of Bata India Ltd?
The Dividend Yield of Bata India Ltd is 2.05 %.
What is the ROCE of Bata India Ltd?
The ROCE of Bata India Ltd is 15.1 %.
What is the ROE of Bata India Ltd?
The ROE of Bata India Ltd is 15.6 %.
What is the Face Value of Bata India Ltd?
The Face Value of Bata India Ltd is 5.00.